ACTG Publications

TitleAuthorsDateJournalIssueVolume
Binge drinking is associated with differences in weekday and weekend adherence in HIV-infected individuals.De Boni, Raquel B ; Zheng, Lu ; Rosenkranz, Susan L ; Sun, Xin ; Lavenberg, Jeffrey ; Cardoso, Sandra W ; Grinsztejn, Beatriz ; La Rosa, Alberto ; Pierre, Samuel ; Severe, Patrice ; Cohn, Susan E ; Collier, Ann C ; Gross, Robert2016 Feb 1Drug Alcohol Depend159
Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial.Flexner, Charles ; Tierney, Camlin ; Gross, Robert ; Andrade, Adriana ; Lalama, Christina ; Eshleman, Susan H ; Aberg, Judith ; Sanne, Ian ; Parsons, Teresa ; Kashuba, Angela ; Rosenkranz, Susan L ; Kmack, Anne ; Ferguson, Elaine ; Dehlinger, Marjorie ; Mildvan, Donna ; ACTG A5073 Study Team2010 Apr 1Clin Infect Dis750
MACH14: a multi-site collaboration on ART adherence among 14 institutions.Liu, Honghu ; Wilson, Ira B ; Goggin, Kathy ; Reynolds, Nancy ; Simoni, Jane M ; Golin, Carol E ; Rosen, Marc I ; Gross, Robert ; Wagner, Glenn ; Remien, Robert H ; Schneiderman, Neil ; Erlen, Judith A ; Arnsten, Julia H ; Bangsberg, David R2013 JanAIDS Behav117
Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial.Gross, Robert ; Tierney, Camlin ; Andrade, Adriana ; Lalama, Christina ; Rosenkranz, Susan ; Eshleman, Susan H ; Flanigan, Timothy ; Santana, Jorge ; Salomon, Nadim ; Reisler, Ronald ; Wiggins, Ilene ; Hogg, Evelyn ; Flexner, Charles ; Mildvan, Donna ; AIDS Clinical Trials Group A5073 Study Team2009 Jul 13Arch Intern Med13169
Partner-Focused Adherence Intervention for Second-line Antiretroviral Therapy: A Multinational Randomized Trial (ACTG A5234).Gross, Robert ; Zheng, Lu ; La Rosa, Alberto ; Sun, Xin ; Rosenkranz, Susan L ; Cardoso, Sandra Wagner ; Ssali, Francis ; Camp, Rob ; Godfrey, Catherine ; Cohn, Susan E ; Robbins, Gregory K ; Chisada, Anthony ; Wallis, Carole L ; Reynolds, Nancy R ; Lu, Darlene ; Safren, Steven A ; Hosey, Lara ; Severe, Patrice ; Collier, Ann C2015 Jan 1Lancet HIV12
Patterns of antiretroviral therapy adherence and impact on HIV RNA among patients in North America.Genberg, Becky L ; Wilson, Ira B ; Bangsberg, David R ; Arnsten, Julia ; Goggin, Kathy ; Remien, Robert H ; Simoni, Jane ; Gross, Robert ; Reynolds, Nancy ; Rosen, Marc ; Liu, Honghu ; MACH14 Investigators2012 Jul 17AIDS1126
Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211.Gulick, Roy M ; Su, Zhaohui ; Flexner, Charles ; Hughes, Michael D ; Skolnik, Paul R ; Wilkin, Timothy J ; Gross, Robert ; Krambrink, Amy ; Coakley, Eoin ; Greaves, Wayne L ; Zolopa, Andrew ; Reichman, Richard ; Godfrey, Catherine ; Hirsch, Martin ; Kuritzkes, Daniel R ; AIDS Clinical Trials Group 5211 Team2007 Jul 15J Infect Dis2196
Three-year safety and efficacy of vicriviroc, a CCR5 antagonist, in HIV-1-infected treatment-experienced patients.Wilkin, Timothy J ; Su, Zhaohui ; Krambrink, Amy ; Long, Jianmin ; Greaves, Wayne ; Gross, Robert ; Hughes, Michael D ; Flexner, Charles ; Skolnik, Paul R ; Coakley, Eoin ; Godfrey, Catherine ; Hirsch, Martin ; Kuritzkes, Daniel R ; Gulick, Roy M2010 AugJ Acquir Immune Defic Syndr554